Advances in T Cells Based on Inflammation in Metabolic Diseases

Advances in T Cells Based on Inflammation in Metabolic Diseases

Blog Article

With the increasing incidence of metabolic diseases year by year and their impact on the incidence of cardiovascular diseases, metabolic diseases have attracted great attention as a collar twojeys major health care problem, but there is still no effective treatment.Oxidative stress and inflammation are the main mechanisms leading to metabolic diseases.T cells are involved in the inflammatory response, which can also regulate the development of metabolic diseases, CD4+ T cells and CD8+ T cells are mainly responsible for the role.Th1 and Th17 differentiated from CD4+ T promote inflammation, while Th2 and Treg inhibit inflammation.

CD8+ T cells also contribute to inflammation.The severity and duration of inflammatory reactions can also lead to different degrees of progression of metabolic diseases.Moreover, mTOR, PI3K-Akt, and AMPK signaling pathways play unique roles in the regulation of T cells, which provide a new direction for the treatment of metabolic diseases in the future.In this review, we will elaborate on the role of T cells jake wire tighteners in regulating inflammation in various metabolic diseases, the signaling pathways that regulate T cells in metabolic diseases, and the latest research progress.